Maze Insider Reports $736K Sale. Here's What Investors Should Know as Stock Plunges 33%

An executive at Maze Therapeutics sold 15,000 shares on March 20, 2026, for approximately $736,000, or about $49.10 per share. This is a routine insider sale and, on its own, is unlikely to materially affect Maze's fundamentals or share price without further context.

Analysis

An executive at Maze Therapeutics sold 15,000 shares on March 20, 2026, for approximately $736,000, or about $49.10 per share. This is a routine insider sale and, on its own, is unlikely to materially affect Maze's fundamentals or share price without further context.